EMA — authorised 22 October 2004
- Marketing authorisation holder: Merus Labs Luxco S.a R.L.
- Status: approved
EMA authorised Enablex on 22 October 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 22 October 2004.
Merus Labs Luxco S.a R.L. holds the EU marketing authorisation.